Sarepta to start new trials on muscle disorder drug | Reuters

See on Scoop.itMyHealthShare Medical Reporter

(Reuters) – Sarepta Therapeutics Inc said it would start new trials to revive the chance of approval for its experimental muscle disorder drug after the U.S. Food and Drug Administration advised the company

MyHealthShare‘s insight:

Sarepta to start new trials on muscle disorder drug | Reuters | @scoopit http://sco.lt/…http://myhealthshare.org

See on in.reuters.com

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s